You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Squamous cell carcinoma antigen 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

Not yet recruiting
  • Head and Neck Cancer
  • +20 more
  • TSC-204-A0201
  • +4 more
  • Scottsdale, Arizona
  • +1 more
Aug 3, 2023

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • Intensity-Modulated Radiation Therapy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Active, not recruiting
  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • +8 more
  • Cetuximab
  • +3 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute (UPCI)
Jan 26, 2023

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Lung Non-Squamous Non-Small Cell Carcinoma
  • +3 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Sargramostim
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Biopsy
  • +8 more
  • (no location specified)
Jun 8, 2023

Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

Active, not recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +35 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +7 more
Jan 3, 2023

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 13, 2023

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab paclitaxel
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Squamous Cell Carcinoma antigen2 in Verruca Vulgaris

Recruiting
  • Verruca Vulgaris
  • Healthy
  • Immunohistochemical staining monoclonal antibodies to SCCA2 (SERPINB4/ SCCA2 antibody)
  • Sohag, Egypt
    Sohag University
Jun 7, 2022

HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cancer
  • cell culture
  • Roma, Lazio, Italy
    Fondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Cadonilimab combined Anlotinib
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 6, 2023

Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2023

Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis

Completed
  • Psoriasis
  • Blood samples
  • Tours, France
    Dermatology Service, University Hospital, Tours
May 30, 2022

Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Neck Dissection
  • Elective neck dissection
  • Therapeutic neck dissection
  • (no location specified)
Apr 10, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Intensity-modulated radiotherapy (IMRT)
  • +3 more
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jun 16, 2023

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 17, 2023

Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

Not yet recruiting
  • Neoplasms
  • +2 more
  • Nivolumab Injection [Opdivo]
  • (no location specified)
Jul 19, 2023

Oral Squamous Cell Carcinoma Trial in Wuhan (Camrelizumab plus TP, TP)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Camrelizumab plus TP
  • TP
  • Wuhan, Hubei, China
    Hospital of Stomatology, Wuhan University
Mar 22, 2023

Esophageal Squamous Cell Carcinoma (ESCC), PD-1 Inhibitors Trial in Zhengzhou (IBI110+Sintilimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma (ESCC)
  • PD-1 Inhibitors
  • Zhengzhou, Henan, China
    Feng Wang
Oct 9, 2023